BLFS: BioLife Solutions Inc. Company Profile & Statistics

About

BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today.

Info & Links

CEO

Roderick de Greef

Headquarters

3303 MONTE VILLA PARKWAY, SUITE 310
BOTHELL, WA 98021, UNITED STATES

Auditor

GRANT THORNTON LLP

Share holders

256

Employees

414

BioLife Solutions Inc. Statistics

Valuation Measures

Market Capitalization²

1.30B

Enterprise Value

1.29B

Enterprise Value/EBITDA(ttm)

-35.68

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

10.34

Price to Book(mrq)

3.90

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

40.96%

Operating Margin(ttm)

-17.65%

Profit Margin(ttm)

-34.07%

Return on Equity(ttm)

-6.61%

Return on Invested Capital(ttm)

-14.34%

Return on Assets(ttm)

-5.54%

Income Statement

Revenue(ttm)

143.38M

Revenue Per Share(ttm)

3.09

Gross Profit(ttm)

53.44M

EBITDA(ttm)³

-36.26M

Net Income Available to Common(ttm)

-46.02M

Diluted EPS(ttm)

-1.06

Share Statistics

Beta (5Y Monthly)

1.91

52-Week Change

47.43%

S&P 500 52-Week Change

12.62%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

46.39M

Dividend Yield

0.00%

Float⁴

45.37M

% Held by Insiders

2.20%

% Held by Institutions

93.24%

Balance Sheet

Total Cash(mrq)

34.37M

Total Cash Per Share(mrq)

0.74

Total Debt(mrq)

21.29M

Total Debt/Equity(mrq)

6.54%

Current Ratio(mrq)

2.78%

Quick Ratio(mrq)

1.78%

Book Value Per Share(mrq)

7.04

Cash Flow

Operating Cash Flow Per Share(ytd)

0.15

Free Cash Flow(ytd)

4.32M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BLFS

BioLife Solutions Inc.

BioLife Solutions Inc. Profile